Flamingo-01 Phase III GP2 Product Press Releases Email Alerts
Greenwich LifeSciences
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GP2 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED PHASE IIB CLINICAL TRIAL
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT
  • ABOUT
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
  • TECHNOLOGY
    • OUR GP2 CANCER IMMUNOTHERAPY PRODUCT
    • CANCER AND IMMUNOTHERAPY OVERVIEW
  • CLINICAL TRIALS
    • COMPLETED PHASE IIB CLINICAL TRIAL
    • FLAMINGO-01 PHASE III CLINICAL TRIAL
  • INVESTORS & MEDIA
    • OVERVIEW
    • NEWS & EVENTS
    • COMPANY INFO
    • STOCK INFO
    • SEC FILINGS
    • GOVERNANCE
  • CONTACT

Press Releases

Nasdaq: GLSI

Investors

  • Overview
  • News & Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Presentations
    • FAQ
  • Stock Info
  • SEC Filings
  • Governance
  • News & Events

  • Press Releases
  • IR Calendar
  • Email Alerts
Mar 10, 2021 7:59pm EST

Greenwich LifeSciences CEO to be Interviewed Live on Benzinga’s Power Hour

Mar 08, 2021 6:00am EST

Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to Manage Phase III Clinical Trial for Recurring Breast Cancer

Mar 02, 2021 6:00am EST

Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences

Feb 25, 2021 6:00am EST

Greenwich LifeSciences Announces Acceptance of Two Abstracts at Upcoming Major Cancer Conference

Jan 29, 2021 11:33am EST

Greenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment Option

Jan 29, 2021 6:00am EST

Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money Report

Jan 21, 2021 6:00am EST

Greenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor Conferences

Jan 08, 2021 6:00am EST

Greenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021 JP Morgan Healthcare Week

Jan 05, 2021 6:00am EST

Greenwich LifeSciences’ LD Micro Presentation Replay Now Available

Dec 24, 2020 6:00am EST

Greenwich LifeSciences to Ring Nasdaq Opening Bell on December 28

  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next
RSS

By proceeding to use this website, you consent to our use of cookies as described in our Privacy Policy.

Email Alerts

Sign up Now

Sign me up for:

  • Tear Sheet
  • RSS Feed
Logo of Greenwich LifeSciences.

Copyright © 2023

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
Privacy Policy
Disclaimer
Sitemap
Logo of Greenwich LifeSciences.

Copyright © 2023

Greenwich LifeSciences, Inc.

ABOUT
TECHNOLOGY
CLINICAL TRIALS
INVESTORS & MEDIA
CONTACT
Disclaimer
Privacy Policy
Sitemap